Aspirin for primary prevention of cardiovascular events in people with diabetes.
Pignone
Michael
M
Department of Medicine, University of North Carolina, Chapel Hill, USA.
Alberts
Mark J
MJ
Colwell
John A
JA
Cushman
Mary
M
Inzucchi
Silvio E
SE
Mukherjee
Debabrata
D
Rosenson
Robert S
RS
Williams
Craig D
CD
Wilson
Peter W
PW
Kirkman
M Sue
MS
D000368:Aged; D001241:Aspirin / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D003327:Coronary Disease / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000379:methods*; D011379:Prognosis; D018570:Risk Assessment; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin